Skip to main content
logo
Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
49.35
+0.64 (1.31%)
At close: Nov 28, 2025, 1:00 PM EST
49.40
+0.05 (0.10%)
After-hours: Nov 28, 2025, 5:00 PM EST

Novo Nordisk Revenue

Novo Nordisk had revenue of 74.98B DKK in the quarter ending September 30, 2025, with 5.14% growth. This brings the company's revenue in the last twelve months to 315.60B, up 16.64% year-over-year. In the year 2024, Novo Nordisk had annual revenue of 290.40B with 25.03% growth.

Revenue (ttm)
315.60B DKK
Revenue Growth
+16.64%
P/S Ratio
4.41
Revenue / Employee
4,080,247 DKK
Employees
77,349
Market Cap
218.70B USD

Revenue Chart

* This company reports financials in DKK.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024290.40B58.14B25.03%
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020126.95B4.93B4.04%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Abbott Laboratories43.84B
Revenue Rankings

NVO News

More News